Test manufacturing and laboratory groups are pushing Congress to move forward with legislative reforms on US FDA and Centers for Medicare and Medicaid Services regulatory oversight of lab developed tests (LDTs) and IVDs this summer, a topic that has been sitting on the back burner of key congressional committees for several years now.
Last year in March, Reps. Larry Bucshon, R-Indiana, and Diana DeGette, D-Colorado, of the House Energy and Commerce Committee came...